Oral efficacy of 2' nor 2' deoxy guanosine against herpes simplex virus type 1 and herpes simplex virus type 2 infections of mice
Dewitt, C.M.; Tolman, R.L.; Field, A.K.
Abstracts of the Annual Meeting of the American Society for Microbiology 83: S36
1983
ISSN/ISBN: 0094-8519 Accession: 028839024
PDF emailed within 1 workday: $29.90
Related References
Cremer, K.; Wohlenberg, C.; Notkins, A.L.; Mackett, M.; Moss, B. 1985: Vaccinia virus recombinant that expresses the herpes simplex virus type 1 glycoprotein d gene protects mice against lethal challenge by herpes simplex virus type 1 or herpes simplex type 2 and the establishment of a latent ganglionic infection by herpes simplex virus type 1 Lerner, R A , R M Chanock And F Brown (Ed ) Vaccines 85: Molecular And Chemical Basis Of Resistance to Parasitic, Bacterial, And Viral Diseases; Meeting, 1983 Xxi+407p Cold Spring Harbor Laboratory: Cold Spring Harbor, N Y , Usa Illus Paper 169-174Davies, M.E.; Bondi, J.V.; Tolman, R.L.; Field, A.K. 1983: Efficacy of 2' nor 2' deoxy guanosine treatment of oro facial herpes simplex virus type 1 infection in mice Abstracts of the Annual Meeting of the American Society for Microbiology 83: S35
Kimura, S.; Okazaki, K. 1984: Expression of a herpes simplex virus glycoprotein in two clonal lines of hamster cells transformed by herpes simplex virus type 2 - Expression d'une glycoprotéine du virus herpès simplex dans deux lignées clonales de cellules de hamster transformées par le virus herpès simplex de type 2 Gann 75(4): 317-324
Hayashi, K.; Hayashi, T.; Miyazawa, K.; Tomoda, A. 2010: Phenoxazine derivatives suppress the infections caused by herpes simplex virus type-1 and herpes simplex virus type-2 intravaginally inoculated into mice Journal of Pharmacological Sciences 114(1): 85-91
Schinazi, R.F.; Fox, J.J.; Watanabe, K.A.; Nahmias, A.J. 1986: Activities of 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-iodocytosine and its metabolites against herpes simplex virus types 1 and 2 in cell culture and in mice infected intracerebrally with herpes simplex virus type 2 Antimicrobial Agents and Chemotherapy 29(1): 77-84
Schinazi, R.F.; Fox, J.J.; Watanabe, K.A.; Nahmias, A.J. 1986: Activities of 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-iodocytosine and its metabolites against herpes simplex virus types 1 and 2 in cell culture and in mice infected intracerebrally with herpes simplex virus type 2 Antimicrobial Agents and Chemotherapy 29(1): 77-84
Wilkie, N.M.; Stow, N.D.; Marsden, H.S.; Preston, V.; Cortini, R.; Timbury, M.C.; Subak Sharpe, J.H. 1979: Physical mapping of herpes simplex virus coded functions and poly peptides by marker rescue and analysis of herpes simplex virus type 1 herpes simplex virus type 2 inter typic recombinants De-The, G , W Henle And F Rapp (Ed ) IARC (International Agency For Research on Cancer) Science Publications, No 24 Oncogenesis And Herpesviruses, Iii Part 1: Dna Of Herpesviruses, Viral Antigens, Cell-Virus Interaction; Proceedings Of The 3rd International Symposium, Cambridge, Mass , Usa, July 25-29, 1977 Lv+580p International Agency For Research on Cancer: Lyon, France Illus P11-32, 1978
Becker, Y.; Gordon, Y.J.; Gilden, D. 1982: Efficacy of immunization with herpes simplex virus type 1 thymidine kinase mutants against experimental herpes simplex virus type 1 infections IOVS Investigative Ophthalmology and Visual Science 22(3): 98
McKendall, R.R. 1977: Efficacy of herpes simplex virus type 1 immunization in protecting against acute and latent infection by herpes simplex virus type 2 in mice Infection and Immunity 16(2): 717-719
Carter, V.C.; Jennings, S.R.; Rice, P.L.; Tevethia, S.S. 1984: Mapping of a herpes simplex virus type 2-encoded function that affects the susceptibility of herpes simplex virus-infected target cells to lysis by herpes simplex virus-specific cytotoxic T lymphocytes Journal of Virology 49(3): 766-771
Ritchie, M.H.; Oakes, J.E.; Lausch, R.N. 1993: Passive transfer of anti-herpes simplex virus type 2 monoclonal and polyclonal antibodies protect against herpes simplex virus type 1-induced but not herpes simplex virus type 2-induced stromal keratitis IOVS Investigative Ophthalmology and Visual Science 34(8): 2460-2468
Althof, F.; Mechtersheimer, M.; Richter, M.; Dietz, A. 2000: Ein Herpes-simplex-Virus Typ 1-induzierter, Tumor im Vestibulum nasi: Die Problematik der Resistenzentwicklung von Herpes-simplex-Viren im Rahmen einer chronisch-lymphatischen B-Zell-Leukämie - Herpes simplex virus type 1-induced, tumor in the nasal vestibule.the problem of resistance development of herpes simplex in a patient with chronic lymphatic B-cell leukemia Hno. Hals-, Nasen-, Ohrenarzte 48(2): 147-151
Brans, R. 2010: Evaluation eines dominantnegativen rekombinanten Herpes-simplex-Virus (HSV) Typ 1 als Impfstoff gegen Herpes genitalis bei Mäusen und Meerschweinchen - Evaluation of a dominant-negative recombinant herpes simplex virus (HSV) type 1 as a vaccine against genital herpes in mice und guinea pigs der Hautarzt 61(12): 1073-1077
Luo, C.; Goshima, F.; Kamakura, M.; Mutoh, Y.; Iwata, S.; Kimura, H.; Nishiyama, Y. 2012: Immunization with a highly attenuated replication-competent herpes simplex virus type 1 mutant, HF10, protects mice from genital disease caused by herpes simplex virus type 2 Frontiers in Microbiology 3: 158
Chen, M.H.; W.J.G.; Skinner, G.R.B.; Hartley, C.E. 1984: Failing in prevention of herpes simplex virus type 2 latency in sensory ganglia of mice with an inactivated subunit vaccine ac nfu 1 s negative bhk prepared from herpes simplex virus type 1 Journal of Cellular Biochemistry Suppl (8 Part B): 205
Shavrina Asher, L.V.; Walz, M.A. 1977: Effect of immunization on the development of a latent ganglionic infection in mice challenged intra vaginally with herpes simplex virus type 1 and herpes simplex virus type 2 Abstracts of the Annual Meeting of the American Society for Microbiology 77: 331
Chen, M.H.; Dong, C.Y.; Liu, Z.H.; Skinner, G.R.; Hartley, C.E. 1983: Prevention of type 2 herpes simplex virus induced cervical carcinoma in mice by prior immunization with a vaccine prepared from type 1 herpes simplex virus Vaccine 1(1): 13-16
Russell, R.G.; Larsen, H.S.; Rouse, B.T. 1982: Protection of mice against lethal herpes simplex virus type 1 infection by herpes simplex virus type 1 primed spleen cells re stimulated in vitro Federation Proceedings 41(3): Abstract 1758
Nakazato, I.; Kinjo, T.; Sirirungsi, W.; Tsuhako, K.; Miyagi, J.; Higa, M.; Iwamasa, T. 2000: Experimental myelitis in BALB/cN and C57BL/6N mice caused by herpes simplex virus type 1 compared with herpes simplex virus type 2 Pathology Research and Practice 196(9): 635-645
Suligoi, B.; Torri, A.; Grilli, G.; Tanzi, E.; Palú, G. 2004: Seroprevalence and seroincidence of herpes simplex virus type 1 and herpes simplex virus type 2 infections in a cohort of adolescents in Italy Sexually Transmitted Diseases 31(10): 608-610